Evidence map›Paper›PMID 30497795›Full record

ArticleLancet (London, England)2018

Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Nicholas Steel, John A Ford, John N Newton, Adrian C J Davis, Theo Vos, Mohsen Naghavi, Scott Glenn, Andrew Hughes, Alice M Dalton, Diane Stockton and 34 more

Erratum issued 2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 127 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 3 pooled it
32.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05495685 unknown statusnot on this mapstarted 2022, after this paper: background citation

Pancreatic Cancer Detection by Liquid Biopsy in Peripheral Blood: A Prospective Study

TypeobservationalSponsorChanghai HospitalRan2022 to 2024Enrolled450ConditionsCancer
NCT05556603 recruitingnot on this mapstarted 2022, after this paper: background citation

Pancreatic Cancer Detection by Liquid Biopsy in Peripheral Blood: A Prospective Study

TypeobservationalSponsorRuijin HospitalRan2022 to 2029Enrolled7,062ConditionsCancer
3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 3 syntheses or guidelines pooled it, 265 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Development and validation of MRI-based radiomics models for predicting recurrence in patients with spine and pelvis chordomas.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 3 countries.

Nicholas SteelUniversity of East Anglia, Norwich, UK. Electronic address: n.steel@uea.ac.uk.
John A FordUniversity of East Anglia, Norwich, UK.
John N NewtonPublic Health England, London, UK.
Adrian C J DavisAD CAVE Solutions Ltd, London, UK; Imperial College London, London, UK.
Theo VosInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Mohsen NaghaviInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Scott GlennInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Andrew HughesPublic Health England, Oxford, UK.
Alice M DaltonUniversity of East Anglia, Norwich, UK.
Diane StocktonNHS Health Scotland, Edinburgh, UK.
Ciaran HumphreysPublic Health Wales, Carmarthen, UK.
Mary DallatPublic Health Agency, Belfast, UK.
Jürgen SchmidtPublic Health England, London, UK.
Julian FlowersPublic Health England, London, UK.
Sebastian FoxPublic Health England, London, UK.
Ibrahim AbubakarUniversity College London, London, UK.
Robert W AldridgeUniversity College London, London, UK.
Allan BakerPublic Health England, London, UK.
Carol BrayneCambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Traolach BrughaDepartment of Health Sciences, College of Life Sciences, University of Leicester, Leicester, UK.
Simon CapewellDepartment of Public Health & Policy, Institute of Psychology, Health & Society, University of Liverpool, Liverpool, UK.
Josip CarImperial College London, London, UK; Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Majid EzzatiImperial College London, London, UK.
Justine FitzpatrickPublic Health England, London, UK.
Felix GreavesPublic Health England, London, UK; Imperial College London, London, UK.
Roderick HayKing's College London, London, UK.
Simon HayInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Frank KeeUKCRC Centre of Excellence for Public Health Research (NI), Queens University of Belfast, Belfast, UK.
Heidi J LarsonInstitute for Health Metrics and Evaluation, Seattle, WA, USA; London School of Hygiene & Tropical Medicine, London, UK.
Ronan A LyonsHealth Data Research UK, Swansea University, Swansea, UK.
Azeem MajeedImperial College London, London, UK.
Martin McKeeLondon School of Hygiene & Tropical Medicine, London, UK.
Salman RawafImperial College London, London, UK.
Harry RutterUniversity of Bath, Bath, UK.
Sonia SaxenaImperial College London, London, UK.
Aziz SheikhUsher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Liam SmeethLondon School of Hygiene & Tropical Medicine, London, UK.
Russell M VinerUniversity College London, London, UK.
Stein Emil VollsetInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Hywel C WilliamsCentre of Evidence-Based Dermatology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Charles WolfeKing's College London, London, UK.
Anthony WoolfBone and Joint Research Group, Royal Cornwall Hospital, Truro, UK.
Christopher J L MurrayInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Institute for Health Metrics and Evaluation · USPublic Health England · GBImperial College London · GBUniversity College London · GBUniversity of East Anglia · GBKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBHealth Data Research UK · GBNanyang Technological University · SGNottingham University Hospitals NHS Trust · GBPublic Health Agency · GBPublic Health Scotland · GBPublic Health Wales · GBQueen's University Belfast · GBRoyal Cornwall Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Bath · GBUniversity of Cambridge · GBUniversity of Edinburgh · GBUniversity of Leicester · GB

Funding

Department of Health 10/33/04Medical Research Council G0400491Medical Research Council G0601019Medical Research Council G0900847Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/2Medical Research Council MR/K006525/1Wellcome Trust
6 · The paper itself

Abstract

backgroundPrevious studies have reported national and regional Global Burden of Disease (GBD) estimates for the UK. Because of substantial variation in health within the UK, action to improve it requires comparable estimates of disease burden and risks at country and local levels. The slowdown in the rate of improvement in life expectancy requires further investigation. We use GBD 2016 data on mortality, causes of death, and disability to analyse the burden of disease in the countries of the UK and within local authorities in England by deprivation quintile.

methodsWe extracted data from the GBD 2016 to estimate years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the UK, and 150 English Upper-Tier Local Authorities. We estimated the burden of disease by cause of death, condition, year, and sex. We analysed the association between burden of disease and socioeconomic deprivation using the Index of Multiple Deprivation. We present results for all 264 GBD causes of death combined and the leading 20 specific causes, and all 84 GBD risks or risk clusters combined and 17 specific risks or risk clusters.

findingsThe leading causes of age-adjusted YLLs in all UK countries in 2016 were ischaemic heart disease, lung cancers, cerebrovascular disease, and chronic obstructive pulmonary disease. Age-standardised rates of YLLs for all causes varied by two times between local areas in England according to levels of socioeconomic deprivation (from 14 274 per 100 000 population [95% uncertainty interval 12 791-15 875] in Blackpool to 6888 [6145-7739] in Wokingham). Some Upper-Tier Local Authorities, particularly those in London, did better than expected for their level of deprivation. Allowing for differences in age structure, more deprived Upper-Tier Local Authorities had higher attributable YLLs for most major risk factors in the GBD. The population attributable fractions for all-cause YLLs for individual major risk factors varied across Upper-Tier Local Authorities. Life expectancy and YLLs have improved more slowly since 2010 in all UK countries compared with 1990-2010. In nine of 150 Upper-Tier Local Authorities, YLLs increased after 2010. For attributable YLLs, the rate of improvement slowed most substantially for cardiovascular disease and breast, colorectal, and lung cancers, and showed little change for Alzheimer's disease and other dementias. Morbidity makes an increasing contribution to overall burden in the UK compared with mortality. The age-standardised UK DALY rate for low back and neck pain (1795 [1258-2356]) was higher than for ischaemic heart disease (1200 [1155-1246]) or lung cancer (660 [642-679]). The leading causes of ill health (measured through YLDs) in the UK in 2016 were low back and neck pain, skin and subcutaneous diseases, migraine, depressive disorders, and sense organ disease. Age-standardised YLD rates varied much less than equivalent YLL rates across the UK, which reflects the relative scarcity of local data on causes of ill health.

interpretationThese estimates at local, regional, and national level will allow policy makers to match resources and priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are needed if the rate of improvement is to recover. A targeted policy response is also required to address the increasing proportion of burden due to morbidity, such as musculoskeletal problems and depression. Improving the quality and completeness of available data on these causes is an essential component of this response.

fundingBill & Melinda Gates Foundation and Public Health England.

Indexed as

Health StatusAdolescentAdultAgedAged, 80 and overCause of DeathChildChild, PreschoolDisability EvaluationFemaleGlobal Burden of DiseaseHealth Status DisparitiesHumansInfantInfant, NewbornLife Expectancy

Identifiers

PMID30497795
PMCPMC6215773
OpenAlexW2898397184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.